25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Innovation Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyze Innovation Pharmaceuticals Inc together

I guess you are interested in Innovation Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Innovation Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Innovation Pharmaceuticals Inc

I send you an email if I find something interesting about Innovation Pharmaceuticals Inc.

1. Quick Overview

1.1. Quick analysis of Innovation Pharmaceuticals Inc (30 sec.)










1.2. What can you expect buying and holding a share of Innovation Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$-0.02
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-20,271.8%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.004
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Innovation Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-0.13 - $0.10
Total Value Per Share
$-0.12 - $0.10

2.2. Growth of Innovation Pharmaceuticals Inc (5 min.)




Is Innovation Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$4.7m-$2.6m-132.0%

How much money is Innovation Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.1m-$7.1m$3.9m126.0%
Net Profit Margin-17,600.0%-39,783.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Innovation Pharmaceuticals Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Innovation Pharmaceuticals Inc?

Welcome investor! Innovation Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Innovation Pharmaceuticals Inc.

First you should know what it really means to hold a share of Innovation Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Innovation Pharmaceuticals Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Innovation Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Innovation Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Innovation Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-6,163.3%-0.01-6,163.3%-0.01-13,698.1%-0.02-15,334.2%-0.02-20,920.1%
Usd Book Value Change Per Share-0.01-5,235.3%-0.01-5,235.3%-0.01-5,406.5%0.001,630.3%0.001,402.5%
Usd Dividend Per Share0.00167.3%0.00167.3%0.00167.3%0.015,720.5%0.002,860.2%
Usd Total Gains Per Share-0.01-5,068.0%-0.01-5,068.0%-0.01-5,239.2%0.017,350.8%0.004,262.8%
Usd Price Per Share0.02-0.02-0.03-0.17-0.81-
Price to Earnings Ratio-3.25--3.25--2.19--11.19--34.67-
Price-to-Total Gains Ratio-3.95--3.95--5.73-11.72--30.77-
Price to Book Ratio5.04-5.04-3.26-28.49-80.61-
Price-to-Total Gains Ratio-3.95--3.95--5.73-11.72--30.77-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.01
Gains per Quarter (10000000 shares)-50,679.5573,507.72
Gains per Year (10000000 shares)-202,718.21294,030.89
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16692-209411-20272822881965212294021
213385-418821-405446457637130424588052
320077-628232-608164686456195637882083
426770-837643-8108829152752608491176114
533462-1047053-101360011440933260611470145
640155-1256464-121631813729123912731764176
746847-1465874-141903616017314564862058207
853539-1675285-162175418305495216982352238
960232-1884696-182447220593685869102646269
1066924-2094106-202719022881876521222940300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.017.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%6.011.00.035.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.05.050.0%6.00.011.035.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.05.00.050.0%7.010.00.041.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Innovation Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.005-0.0050%-0.005+3%0.002-421%0.001-473%
Book Value Per Share--0.0040.0040%0.009-57%0.005-12%0.004+6%
Current Ratio--0.3250.3250%0.822-60%0.739-56%0.699-53%
Debt To Asset Ratio--0.7290.7290%0.544+34%0.922-21%0.924-21%
Debt To Equity Ratio--2.6872.6870%1.194+125%2.022+33%2.201+22%
Dividend Per Share--0.0000.0000%0.0000%0.006-97%0.003-94%
Eps---0.006-0.0060%-0.014+122%-0.015+149%-0.021+239%
Free Cash Flow Per Share---0.004-0.0040%-0.012+194%-0.011+166%-0.017+307%
Free Cash Flow To Equity Per Share---0.004-0.0040%-0.005+4%0.001-475%0.000-1021%
Gross Profit Margin--1.0021.0020%1.0040%1.016-1%1.008-1%
Intrinsic Value_10Y_max--0.100--------
Intrinsic Value_10Y_min---0.128--------
Intrinsic Value_1Y_max---0.007--------
Intrinsic Value_1Y_min---0.016--------
Intrinsic Value_3Y_max---0.007--------
Intrinsic Value_3Y_min---0.046--------
Intrinsic Value_5Y_max--0.008--------
Intrinsic Value_5Y_min---0.073--------
Market Cap51401.402-19900%10280280.32010280280.3200%15420420.480-33%88616016.358-88%413878945.543-98%
Net Profit Margin---176.000-176.0000%-397.833+126%-280.942+60%-140.471-20%
Operating Margin---9.556-9.5560%-384.778+3927%-160.278+1577%-80.139+739%
Operating Ratio--184.000184.0000%397.667-54%200.403-8%100.202+84%
Pb Ratio0.025-19900%5.0425.0420%3.260+55%28.495-82%80.609-94%
Pe Ratio-0.016+100%-3.245-3.2450%-2.190-33%-11.195+245%-34.668+968%
Price Per Share0.000-19900%0.0200.0200%0.030-33%0.172-88%0.805-98%
Price To Free Cash Flow Ratio-0.024+100%-4.746-4.7460%-2.425-49%-16.597+250%-39.825+739%
Price To Total Gains Ratio-0.020+100%-3.946-3.9460%-5.726+45%11.720-134%-30.768+680%
Quick Ratio--0.3020.3020%0.792-62%0.710-57%0.665-55%
Return On Assets---0.421-0.4210%-0.690+64%-1.084+157%-1.243+195%
Return On Equity---1.554-1.5540%-1.514-3%-2.071+33%-2.340+51%
Total Gains Per Share---0.005-0.0050%-0.005+3%0.007-169%0.004-219%
Usd Book Value--2039000.0002039000.0000%4730000.000-57%2322200.000-12%1919000.000+6%
Usd Book Value Change Per Share---0.005-0.0050%-0.005+3%0.002-421%0.001-473%
Usd Book Value Per Share--0.0040.0040%0.009-57%0.005-12%0.004+6%
Usd Dividend Per Share--0.0000.0000%0.0000%0.006-97%0.003-94%
Usd Eps---0.006-0.0060%-0.014+122%-0.015+149%-0.021+239%
Usd Free Cash Flow---2166000.000-2166000.0000%-6360000.000+194%-5751600.000+166%-8821500.000+307%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.012+194%-0.011+166%-0.017+307%
Usd Free Cash Flow To Equity Per Share---0.004-0.0040%-0.005+4%0.001-475%0.000-1021%
Usd Market Cap51401.402-19900%10280280.32010280280.3200%15420420.480-33%88616016.358-88%413878945.543-98%
Usd Price Per Share0.000-19900%0.0200.0200%0.030-33%0.172-88%0.805-98%
Usd Profit---3168000.000-3168000.0000%-7161000.000+126%-9027800.000+185%-11128100.000+251%
Usd Revenue--18000.00018000.0000%18000.0000%96400.000-81%48200.000-63%
Usd Total Gains Per Share---0.005-0.0050%-0.005+3%0.007-169%0.004-219%
 EOD+3 -5MRQTTM+0 -0YOY+20 -135Y+14 -2210Y+16 -20

3.3 Fundamental Score

Let's check the fundamental score of Innovation Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.016
Price to Book Ratio (EOD)Between0-10.025
Net Profit Margin (MRQ)Greater than0-176.000
Operating Margin (MRQ)Greater than0-9.556
Quick Ratio (MRQ)Greater than10.302
Current Ratio (MRQ)Greater than10.325
Debt to Asset Ratio (MRQ)Less than10.729
Debt to Equity Ratio (MRQ)Less than12.687
Return on Equity (MRQ)Greater than0.15-1.554
Return on Assets (MRQ)Greater than0.05-0.421
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Innovation Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.698
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Innovation Pharmaceuticals Inc

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

Fundamental data was last updated by Penke on 2024-11-15 11:25:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Innovation Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Innovation Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -17,600.0% means that $-176.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Innovation Pharmaceuticals Inc:

  • The MRQ is -17,600.0%. The company is making a huge loss. -2
  • The TTM is -17,600.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-17,600.0%TTM-17,600.0%0.0%
TTM-17,600.0%YOY-39,783.3%+22,183.3%
TTM-17,600.0%5Y-28,094.2%+10,494.2%
5Y-28,094.2%10Y-14,047.1%-14,047.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17,600.0%-120.2%-17,479.8%
TTM-17,600.0%-210.7%-17,389.3%
YOY-39,783.3%-219.8%-39,563.5%
5Y-28,094.2%-348.0%-27,746.2%
10Y-14,047.1%-473.2%-13,573.9%
4.3.1.2. Return on Assets

Shows how efficient Innovation Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Innovation Pharmaceuticals Inc to the Biotechnology industry mean.
  • -42.1% Return on Assets means that Innovation Pharmaceuticals Inc generated $-0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Innovation Pharmaceuticals Inc:

  • The MRQ is -42.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -42.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.1%TTM-42.1%0.0%
TTM-42.1%YOY-69.0%+26.9%
TTM-42.1%5Y-108.4%+66.3%
5Y-108.4%10Y-124.3%+15.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.1%-11.0%-31.1%
TTM-42.1%-11.8%-30.3%
YOY-69.0%-11.3%-57.7%
5Y-108.4%-12.6%-95.8%
10Y-124.3%-14.3%-110.0%
4.3.1.3. Return on Equity

Shows how efficient Innovation Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Innovation Pharmaceuticals Inc to the Biotechnology industry mean.
  • -155.4% Return on Equity means Innovation Pharmaceuticals Inc generated $-1.55 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Innovation Pharmaceuticals Inc:

  • The MRQ is -155.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -155.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-155.4%TTM-155.4%0.0%
TTM-155.4%YOY-151.4%-4.0%
TTM-155.4%5Y-207.1%+51.8%
5Y-207.1%10Y-234.0%+26.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-155.4%-14.1%-141.3%
TTM-155.4%-15.8%-139.6%
YOY-151.4%-13.9%-137.5%
5Y-207.1%-18.5%-188.6%
10Y-234.0%-19.2%-214.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Innovation Pharmaceuticals Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Innovation Pharmaceuticals Inc is operating .

  • Measures how much profit Innovation Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Innovation Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of -955.6% means the company generated $-9.56  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Innovation Pharmaceuticals Inc:

  • The MRQ is -955.6%. The company is operating very inefficient. -2
  • The TTM is -955.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-955.6%TTM-955.6%0.0%
TTM-955.6%YOY-38,477.8%+37,522.2%
TTM-955.6%5Y-16,027.8%+15,072.3%
5Y-16,027.8%10Y-8,013.9%-8,013.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-955.6%-267.8%-687.8%
TTM-955.6%-313.4%-642.2%
YOY-38,477.8%-224.0%-38,253.8%
5Y-16,027.8%-385.5%-15,642.3%
10Y-8,013.9%-498.7%-7,515.2%
4.3.2.2. Operating Ratio

Measures how efficient Innovation Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 184.00 means that the operating costs are $184.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Innovation Pharmaceuticals Inc:

  • The MRQ is 184.000. The company is inefficient in keeping operating costs low. -1
  • The TTM is 184.000. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ184.000TTM184.0000.000
TTM184.000YOY397.667-213.667
TTM184.0005Y200.403-16.403
5Y200.40310Y100.202+100.202
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ184.0002.631+181.369
TTM184.0003.412+180.588
YOY397.6673.299+394.368
5Y200.4034.788+195.615
10Y100.2026.538+93.664
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Innovation Pharmaceuticals Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Innovation Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.33 means the company has $0.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Innovation Pharmaceuticals Inc:

  • The MRQ is 0.325. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.325. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.325TTM0.3250.000
TTM0.325YOY0.822-0.497
TTM0.3255Y0.739-0.414
5Y0.73910Y0.699+0.041
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3253.690-3.365
TTM0.3253.875-3.550
YOY0.8224.684-3.862
5Y0.7395.946-5.207
10Y0.6996.274-5.575
4.4.3.2. Quick Ratio

Measures if Innovation Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Innovation Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.30 means the company can pay off $0.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Innovation Pharmaceuticals Inc:

  • The MRQ is 0.302. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.302. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.302TTM0.3020.000
TTM0.302YOY0.792-0.489
TTM0.3025Y0.710-0.408
5Y0.71010Y0.665+0.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3023.122-2.820
TTM0.3023.451-3.149
YOY0.7924.498-3.706
5Y0.7105.922-5.212
10Y0.6656.414-5.749
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Innovation Pharmaceuticals Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Innovation Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Innovation Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.73 means that Innovation Pharmaceuticals Inc assets are financed with 72.9% credit (debt) and the remaining percentage (100% - 72.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Innovation Pharmaceuticals Inc:

  • The MRQ is 0.729. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.729. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.729TTM0.7290.000
TTM0.729YOY0.544+0.184
TTM0.7295Y0.922-0.193
5Y0.92210Y0.924-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7290.353+0.376
TTM0.7290.350+0.379
YOY0.5440.311+0.233
5Y0.9220.367+0.555
10Y0.9240.382+0.542
4.5.4.2. Debt to Equity Ratio

Measures if Innovation Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Innovation Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 268.7% means that company has $2.69 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Innovation Pharmaceuticals Inc:

  • The MRQ is 2.687. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.687. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.687TTM2.6870.000
TTM2.687YOY1.194+1.492
TTM2.6875Y2.022+0.664
5Y2.02210Y2.201-0.179
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6870.393+2.294
TTM2.6870.435+2.252
YOY1.1940.378+0.816
5Y2.0220.451+1.571
10Y2.2010.493+1.708
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Innovation Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Innovation Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -3.25 means the investor is paying $-3.25 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Innovation Pharmaceuticals Inc:

  • The EOD is -0.016. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.245. Based on the earnings, the company is expensive. -2
  • The TTM is -3.245. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.016MRQ-3.245+3.229
MRQ-3.245TTM-3.2450.000
TTM-3.245YOY-2.190-1.055
TTM-3.2455Y-11.195+7.950
5Y-11.19510Y-34.668+23.473
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.016-2.126+2.110
MRQ-3.245-2.454-0.791
TTM-3.245-3.147-0.098
YOY-2.190-3.335+1.145
5Y-11.195-6.070-5.125
10Y-34.668-6.597-28.071
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Innovation Pharmaceuticals Inc:

  • The EOD is -0.024. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.746. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.746. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.024MRQ-4.746+4.722
MRQ-4.746TTM-4.7460.000
TTM-4.746YOY-2.425-2.322
TTM-4.7465Y-16.597+11.851
5Y-16.59710Y-39.825+23.228
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.024-2.981+2.957
MRQ-4.746-3.363-1.383
TTM-4.746-3.667-1.079
YOY-2.425-4.535+2.110
5Y-16.597-8.343-8.254
10Y-39.825-9.276-30.549
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Innovation Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5.04 means the investor is paying $5.04 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Innovation Pharmaceuticals Inc:

  • The EOD is 0.025. Based on the equity, the company is cheap. +2
  • The MRQ is 5.042. Based on the equity, the company is overpriced. -1
  • The TTM is 5.042. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD0.025MRQ5.042-5.017
MRQ5.042TTM5.0420.000
TTM5.042YOY3.260+1.782
TTM5.0425Y28.495-23.453
5Y28.49510Y80.609-52.115
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0251.863-1.838
MRQ5.0422.028+3.014
TTM5.0422.339+2.703
YOY3.2602.391+0.869
5Y28.4953.666+24.829
10Y80.6094.360+76.249
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets7,517
Total Liabilities5,478
Total Stockholder Equity2,039
 As reported
Total Liabilities 5,478
Total Stockholder Equity+ 2,039
Total Assets = 7,517

Assets

Total Assets7,517
Total Current Assets1,634
Long-term Assets5,883
Total Current Assets
Cash And Cash Equivalents 1,518
Other Current Assets 116
Total Current Assets  (as reported)1,634
Total Current Assets  (calculated)1,634
+/-0
Long-term Assets
Long Term Investments 3,806
Intangible Assets 1,999
Long-term Assets Other 78
Long-term Assets  (as reported)5,883
Long-term Assets  (calculated)5,883
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,021
Long-term Liabilities457
Total Stockholder Equity2,039
Total Current Liabilities
Short-term Debt 268
Short Long Term Debt 213
Accounts payable 1,499
Other Current Liabilities 3,107
Total Current Liabilities  (as reported)5,021
Total Current Liabilities  (calculated)5,087
+/- 66
Long-term Liabilities
Capital Lease Obligations 55
Long-term Liabilities  (as reported)457
Long-term Liabilities  (calculated)55
+/- 402
Total Stockholder Equity
Common Stock52
Retained Earnings -125,325
Other Stockholders Equity 127,312
Total Stockholder Equity (as reported)2,039
Total Stockholder Equity (calculated)2,039
+/-0
Other
Capital Stock52
Cash and Short Term Investments 1,518
Common Stock Shares Outstanding 505,767
Current Deferred Revenue-3,198
Liabilities and Stockholders Equity 7,517
Net Debt -1,250
Net Invested Capital 2,252
Net Tangible Assets 40
Net Working Capital -3,387
Short Long Term Debt Total 268



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
> Total Assets 
21
23
450
155
102
313
28
2,971
10,852
14,319
11,445
9,112
6,541
4,046
9,248
14,299
10,379
7,517
7,51710,37914,2999,2484,0466,5419,11211,44514,31910,8522,971283131021554502321
   > Total Current Assets 
9
12
450
155
102
313
28
2,960
5,556
8,769
6,686
4,475
2,600
625
6,110
10,689
3,952
1,634
1,6343,95210,6896,1106252,6004,4756,6868,7695,5562,96028313102155450129
       Cash And Cash Equivalents 
9
12
352
140
4
69
28
2,955
4,988
8,410
6,310
4,141
2,424
579
6,018
10,194
3,807
1,518
1,5183,80710,1946,0185792,4244,1416,3108,4104,9882,95528694140352129
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
78
0
0
0
0
0
0000078000000000000
       Net Receivables 
0
0
0
0
0
204
0
0
0
12
26
26
29
0
0
0
0
0
000002926261200020400000
       Other Current Assets 
0
0
98
15
98
40
0
5
568
359
376
334
98
46
184
990
290
116
1162909901844698334376359568504098159800
   > Long-term Assets 
12
11
0
0
0
0
0
10
5,296
5,550
4,759
4,637
3,941
3,421
3,138
3,610
6,427
5,883
5,8836,4273,6103,1383,4213,9414,6374,7595,5505,29610000001112
       Property Plant Equipment 
0
0
0
0
0
0
0
0
39
38
90
120
2
1
0
0
0
0
00001212090383900000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,978
3,806
3,8063,9780000000000000000
       Intangible Assets 
12
11
0
0
0
0
0
10
4,962
5,018
4,311
4,212
3,780
3,342
3,060
2,754
2,312
1,999
1,9992,3122,7543,0603,3423,7804,2124,3115,0184,96210000001112
       Other Assets 
0
0
0
0
0
0
0
0
295
494
436
305
0
78
78
856
137
0
01378567878030543649429500000000
> Total Liabilities 
0
5
812
1,948
4,899
7,601
7,654
8,141
9,646
7,295
8,481
10,576
8,692
8,175
7,786
6,790
5,649
5,478
5,4785,6496,7907,7868,1758,69210,5768,4817,2959,6468,1417,6547,6014,8991,94881250
   > Total Current Liabilities 
0
5
412
1,948
4,899
6,768
7,379
8,141
9,646
7,295
8,481
10,576
8,692
7,296
7,369
6,538
4,808
5,021
5,0214,8086,5387,3697,2968,69210,5768,4817,2959,6468,1417,3796,7684,8991,94841250
       Short-term Debt 
0
0
0
432
1,465
167
0
2
2,022
2,022
2,022
2,022
2,022
1,922
2,039
1,620
447
268
2684471,6202,0391,9222,0222,0222,0222,0222,022201671,465432000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
2,022
2,022
2,022
2,022
2,022
1,922
1,901
1,455
250
213
2132501,4551,9011,9222,0222,0222,0222,0222,02200000000
       Accounts payable 
0
0
14
340
1,187
2,140
270
1,849
956
1,838
3,528
4,699
3,185
2,127
557
1,077
1,081
1,499
1,4991,0811,0775572,1273,1854,6993,5281,8389561,8492702,1401,1873401400
       Other Current Liabilities 
0
5
398
1,176
2,247
4,461
7,109
6,290
1,400
3,435
2,931
3,855
3,303
3,247
4,575
3,634
3,132
3,107
3,1073,1323,6344,5753,2473,3033,8552,9313,4351,4006,2907,1094,4612,2471,17639850
   > Long-term Liabilities 
0
0
400
0
0
833
275
2,022
2,022
2,022
2,022
2,022
2,022
879
417
252
841
457
4578412524178792,0222,0222,0222,0222,0222,0222758330040000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
295
494
358
227
159
0
0
778
59
0
0597780015922735849429500000000
> Total Stockholder Equity
21
19
-362
-1,793
-4,798
-7,288
-7,626
-5,170
1,206
7,024
2,964
-1,464
-2,151
-4,129
1,462
7,509
4,730
2,039
2,0394,7307,5091,462-4,129-2,151-1,4642,9647,0241,206-5,170-7,626-7,288-4,798-1,793-3621921
   Common Stock
1
1
9
9
9
9
9
10
11
12
12
14
17
21
33
44
51
52
52514433211714121211109999911
   Retained Earnings -125,325-122,157-115,116-101,244-94,596-85,915-69,553-54,017-41,165-28,020-19,773-16,337-11,377-5,439-2,005-520-81-34
   Capital Surplus 000000000000000000
   Treasury Stock000000-220000-2750000000
   Other Stockholders Equity 
54
99
149
203
632
4,080
8,701
14,593
29,215
48,177
56,969
68,075
83,747
90,446
102,660
122,566
126,836
127,312
127,312126,836122,566102,66090,44683,74768,07556,96948,17729,21514,5938,7014,0806322031499954



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue18
Cost of Revenue-373
Gross Profit-373-355
 
Operating Income (+$)
Gross Profit-373
Operating Expense-2,939
Operating Income-172-3,312
 
Operating Expense (+$)
Research Development1,462
Selling General Administrative995
Selling And Marketing Expenses5
Operating Expense2,9392,462
 
Net Interest Income (+$)
Interest Income0
Interest Expense-28
Other Finance Cost-29
Net Interest Income-57
 
Pretax Income (+$)
Operating Income-172
Net Interest Income-57
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,1682,824
EBIT - interestExpense = -200
-2,996
-3,140
Interest Expense28
Earnings Before Interest and Taxes (EBIT)-172-3,140
Earnings Before Interest and Taxes (EBITDA)-172
 
After tax Income (+$)
Income Before Tax-3,168
Tax Provision-0
Net Income From Continuing Ops-3,168-3,168
Net Income-3,168
Net Income Applicable To Common Shares-3,168
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,939
Total Other Income/Expenses Net-2,99657
 

Technical Analysis of Innovation Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Innovation Pharmaceuticals Inc. The general trend of Innovation Pharmaceuticals Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Innovation Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Innovation Pharmaceuticals Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.004 < 0.004 < 0.004.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Innovation Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Innovation Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Innovation Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Innovation Pharmaceuticals Inc. The current macd is -0.00016119.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Innovation Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Innovation Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Innovation Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Innovation Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartInnovation Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Innovation Pharmaceuticals Inc. The current adx is 67.55.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Innovation Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Innovation Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Innovation Pharmaceuticals Inc. The current sar is 0.0149936.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Innovation Pharmaceuticals Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Innovation Pharmaceuticals Inc. The current rsi is 42.70. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Innovation Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartInnovation Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Innovation Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Innovation Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Innovation Pharmaceuticals Inc Daily Stochastic Oscillator ChartInnovation Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Innovation Pharmaceuticals Inc. The current cci is -61.7816092.

Innovation Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartInnovation Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Innovation Pharmaceuticals Inc. The current cmo is -24.21938247.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Innovation Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartInnovation Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Innovation Pharmaceuticals Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Innovation Pharmaceuticals Inc Daily Williams %R ChartInnovation Pharmaceuticals Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Innovation Pharmaceuticals Inc. The current atr is 0.00096774.

Innovation Pharmaceuticals Inc Daily Average True Range (ATR) ChartInnovation Pharmaceuticals Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Innovation Pharmaceuticals Inc. The current obv is 12,107,221.

Innovation Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartInnovation Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Innovation Pharmaceuticals Inc. The current mfi is 35.15.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Innovation Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartInnovation Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Innovation Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Innovation Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Innovation Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.698
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Innovation Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Innovation Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Innovation Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Innovation Pharmaceuticals Inc

I send you an email if I find something interesting about Innovation Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Innovation Pharmaceuticals Inc.

Receive notifications about Innovation Pharmaceuticals Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.